ロード中...
Antibody-based therapy of acute myeloid leukemia with gemtuzumab ozogamicin
Antibodies have created high expectations for effective yet tolerated therapeutics in acute myeloid leukemia (AML). Hitherto the most exploited target is CD33, a myeloid differentiation antigen found on AML blasts in most patients and, perhaps, leukemic stem cells in some. Treatment efforts have foc...
保存先:
| 主要な著者: | , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2013
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3683663/ https://ncbi.nlm.nih.gov/pubmed/23747885 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|